Athens Medical C.S.A. (ATH:IATR)
Greece · Delayed Price · Currency is EUR 1.780
-0.070 (-3.78%)
Jul 1, 2026, 5:12 PM EET
Athens Medical C.S.A. Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 275.75 | 269.85 | 258.36 | 233.42 | 226 | |
Revenue Growth (YoY) | 2.19% | 4.44% | 10.69% | 3.28% | 20.53% |
Cost of Revenue | 219.61 | 209.08 | 191.81 | 176.61 | 168.21 |
Gross Profit | 56.14 | 60.76 | 66.56 | 56.81 | 57.79 |
Selling, General & Admin | 49.7 | 47.44 | 45.5 | 40.63 | 37.26 |
Other Operating Expenses | -1.4 | -1.83 | -2 | -2.39 | -2.91 |
Operating Expenses | 48.31 | 45.81 | 43.68 | 38.54 | 35.05 |
Operating Income | 7.83 | 14.96 | 22.87 | 18.28 | 22.73 |
Interest Expense | -11.35 | -10.7 | -9.33 | -7.64 | -6.55 |
Interest & Investment Income | 0.12 | 0.32 | 0.33 | 0.12 | 0.2 |
Other Non Operating Income (Expenses) | 0.31 | -0.13 | -0.13 | -0.13 | -0.13 |
EBT Excluding Unusual Items | -3.09 | 4.45 | 13.75 | 10.64 | 16.26 |
Gain (Loss) on Sale of Investments | 0.09 | - | - | - | - |
Gain (Loss) on Sale of Assets | -0.01 | 0.05 | -0.05 | 0.08 | -1.37 |
Other Unusual Items | - | - | - | - | 0.45 |
Pretax Income | -3.01 | 4.5 | 13.7 | 10.71 | 15.34 |
Income Tax Expense | 1.61 | 2.61 | 5.54 | 3.8 | 3.3 |
Earnings From Continuing Operations | -4.62 | 1.89 | 8.16 | 6.92 | 12.04 |
Earnings From Discontinued Operations | - | - | - | - | 3.1 |
Net Income to Company | -4.62 | 1.89 | 8.16 | 6.92 | 15.14 |
Minority Interest in Earnings | -0.05 | -0.11 | -0.08 | -0.07 | -0.09 |
Net Income | -4.67 | 1.78 | 8.08 | 6.85 | 15.05 |
Net Income to Common | -4.67 | 1.78 | 8.08 | 6.85 | 15.05 |
Net Income Growth | - | -77.99% | 18.05% | -54.51% | 283.54% |
Shares Outstanding (Basic) | 87 | 87 | 87 | 87 | 87 |
Shares Outstanding (Diluted) | 87 | 87 | 87 | 87 | 87 |
EPS (Basic) | -0.05 | 0.02 | 0.09 | 0.08 | 0.17 |
EPS (Diluted) | -0.05 | 0.02 | 0.09 | 0.08 | 0.17 |
EPS Growth | - | -77.99% | 18.05% | -54.51% | 283.54% |
Free Cash Flow | -11.83 | 19.82 | 3.78 | -15.75 | 4.47 |
Free Cash Flow Per Share | -0.14 | 0.23 | 0.04 | -0.18 | 0.05 |
Dividend Per Share | - | - | 0.020 | - | 0.070 |
Gross Margin | 20.36% | 22.52% | 25.76% | 24.34% | 25.57% |
Operating Margin | 2.84% | 5.54% | 8.85% | 7.83% | 10.06% |
Profit Margin | -1.69% | 0.66% | 3.13% | 2.93% | 6.66% |
Free Cash Flow Margin | -4.29% | 7.34% | 1.46% | -6.75% | 1.98% |
EBITDA | 19.69 | 25.78 | 32.85 | 27.64 | 31.48 |
EBITDA Margin | 7.14% | 9.55% | 12.71% | 11.84% | 13.93% |
D&A For EBITDA | 11.86 | 10.83 | 9.98 | 9.36 | 8.75 |
EBIT | 7.83 | 14.96 | 22.87 | 18.28 | 22.73 |
EBIT Margin | 2.84% | 5.54% | 8.85% | 7.83% | 10.06% |
Effective Tax Rate | - | 58.06% | 40.44% | 35.44% | 21.51% |